...
【24h】

Percutaneous transhepatic access for catheter ablation of cardiac arrhythmias.

机译:经皮经肝通路用于消融心律失常。

获取原文
获取原文并翻译 | 示例
           

摘要

Femoral venous access may be limited in certain patients undergoing electrophysiology (EP) study and ablation. The purpose of this study is to review a series of patients undergoing percutaneous transhepatic access to allow for ablation of cardiac arrhythmias.Six patients with a variety of cardiac arrhythmias and venous abnormalities underwent percutaneous transhepatic access. Under fluoroscopic and ultrasound guidance, a percutaneous needle was advanced into a hepatic vein and exchanged for a vascular sheath over a wire. Electrophysiology study and radiofrequency ablation was then performed. All tachycardias, including atrial tachycardia, atrial flutter, atrioventricular nodal tachycardia, and atrial fibrillation, were ablated. Procedural times ranged from 227 to 418 min. Fluoroscopy times ranged from 32 to 95 min. There were no complications. All six patients have been arrhythmia-free in follow-up (5-49 months, mean 23.1 months).Percutaneous transhepatic access is safe and feasible in patients with limited venous access who are undergoing EP study and ablation for a range of cardiac arrhythmias.
机译:在某些接受电生理学(EP)研究和消融的患者中,股静脉的进入可能受到限制。这项研究的目的是回顾一系列经皮肝穿刺入路的患者,以允许消融心律失常。六名患有各种心律不齐和静脉异常的患者进行了经皮肝穿刺入路。在荧光镜和超声仪的引导下,将经皮针头刺入肝静脉,并用金属丝换成血管鞘。然后进行电生理研究和射频消融。消融了所有的心动过速,包括房性心动过速,房扑,房室结性心动过速和房颤。程序时间从227到418分钟不等。透视时间为32至95分钟。没有并发症。所有6例患者在随访中均无心律失常(5-49个月,平均23.1个月)。对于经静脉血流受限,正在接受EP研究和消融一系列心律不齐的患者,经皮肝穿刺是安全可行的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号